Leading needle-free technology the Bionector way

As the pioneer of needle-free device technology, Bionector is still the number one choice for many hospitals focused on minimising the risks of catheter occlusion and catheter-related bloodstream infections (CRBSIs).

The features that made Bionector a game changer 10 years ago are still as relevant today in spite of ever increasing competition in the needle-free device market.

With Bionector in place, clinicians can infuse, inject sample and change the IV tubing without exposing the circuit to the atmosphere. Bionector’s membrane automatically opens the fluid pathway only when a male Luer is disconnected, the membrane automatically seals the fluid pathway.

The key features include:

· Seven days or 360 connections to minimise patient discomfort caused by the removal and replacement of lines

· Direct straight fluid pathway to ensure adequate flushing and reduce the internal surface for potential biofilm development

· Neutral displacement of fluid to prevent blood reflux to the tip and minimise catheter occlusion

· Minimal dead space to minimise the surfaces that infusates can contaminate and where biofilm can develop

· Can be used with power injectors (CT-scan). Pressure resistance: 350 psi

· MRI conditional

For patients with high risk of persistent withdrawal occlusion or total occlusions on CVCs, PICCs and midlines in critical care and ICU, there is Bionector TKO.

Combining the needle-free access benefits of Bionector with a pressure-activated bi-directional valve to eliminate catheter tip reflux and catheter occlusions, TKO’s internal valve opens on injection and infusion. If the pressure is too low (such as the IV bag running dry), the valve closes protecting the patient by preventing blood reflux. The internal valve opens under a withdrawal pressure of 7.0psi. If venous pressure changes occur, the internal valve stays closed, preventing reflux at the catheter tip.


Don’t just take our word for it, click the link below to read what global opinion leaders think about Bionector.

Click here


Published 13th August 2019